Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
   See Why FDA Hit Red Light On Kura's Early-Stage Leukemia Trial
   
  November 24, 2021
  Tickers 
   KURA
  
  
  From Benzinga
 
   Aptevo Stock Rallies After Posting First Complete Remission In Early Acute Myeloid Leukemia Trial
   
  November 23, 2021
  Tickers 
   APVO
  
  
  From Benzinga
 
   Dermata's Aesthetic Improvement Candidate Fails To Impress - Read Why
   
  November 19, 2021
  Tickers 
   DRMA
  
  
  From Benzinga
 
   Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
   
  
  
  November 19, 2021
  From Benzinga
 
   Safety Signals Force Enanta To Stop EDP-721 HBV Program
   
  November 19, 2021
  Tickers 
   ENTA
  
  
  From Benzinga
 
   Plus Therapeutics' Targeted Radiotherapy Shows Encouraging Overall Survival In Brain Tumour Trial
   
  November 18, 2021
  Tickers 
   PSTV
  
  
  From Benzinga
 From Benzinga
 
   Moderna Posts Interim Data From mRNA Triplet Program In Solid Tumors
   
  
  
  November 15, 2021
  From Benzinga
 
   Agenus Posts Early Data For CTLA-4 Drug Candidate Across Tumor Types
   
  November 12, 2021
  Tickers 
   AGEN
  
  
  From Benzinga
 
   Freeline Therapeutics Touts Encouraging Data From Fabry Disease Program
   
  November 10, 2021
  Tickers 
   FRLN
  
  
  From Benzinga
 
   Yumanity Therapeutics Stock Plunges After Parkinson's Trial Data
   
  November 10, 2021
  Tickers 
   YMTX
  
  
  From Benzinga
 
   Terns' Potential NASH Candidate Shows Potent Liver Target Engagement
   
  November 10, 2021
  Tickers 
   TERN
  
  
  From Benzinga
 
   Takeda, Shattuck Labs Terminate Immuno-Oncology Pact
   
  
  
  November 09, 2021
  From Benzinga
 
   ALX Oncology Falls After Updated Data For Solid Tumors Candidate
   
  
  
  November 09, 2021
  From Benzinga
 From Benzinga
 From Benzinga
 
   Moderna Scraps mRNA-Based Antibody Program Targeting Chikungunya Virus
   
  November 04, 2021
  Tickers 
   MRNA
  
  
  From Benzinga
 
   Equillium Reveals Early Safety Data For Itolizumab In Lupus Patients
   
  November 02, 2021
  Tickers 
   EQ
  
  
  From Benzinga
 
   Cabaletta Posts Cell Therapy Data From Third Cohort Of Autoimmune Skin Disorder Trial
   
  November 01, 2021
  Tickers 
   CABA
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

